India responds to calls to resist medicine monopolies in RCEP

October 26, 2017: MSF (Doctors without Borders) has called for India and other countries to block RCEP proposals from Japan and South Korea that would allow pharmaceutical companies to have stronger monopolies, prevent competition and keep medicine prices high. They added that it was time to end the push for ever-higher levels of monopoly control of medicines through free trade agreements . RCEP negotiators are meeting in Incheon, South Korea this week.

The Wire reports that a spokesperson for the Indian government has responded that this is a 'red line' for India and some other countries, and they would not agree to any proposals that would prevent competition and threaten India’s ability to continue to be a supplier of cheap generic medicines.

Other major disagreements are reported on tariff levels, investor rights to sue governments, electronic commerce, trade in services and government procurement.